Epitope prediction and identification- adaptive T cell responses in humans.

[1]  S. Mallal,et al.  Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans , 2020, Science.

[2]  P. J. Norris,et al.  Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction Determination , 2020, ImmunoHorizons.

[3]  Brandon Carter,et al.  Computationally Optimized SARS-CoV-2 MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions , 2020, Cell Systems.

[4]  Alex Rubinsteyn,et al.  MHCflurry 2.0: Improved Pan-Allele Prediction of MHC Class I-Presented Peptides by Incorporating Antigen Processing. , 2020, Cell systems.

[5]  A. Sette,et al.  Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome , 2020, Science Immunology.

[6]  T. Hinks,et al.  MAIT Cell Activation and Functions , 2020, Frontiers in Immunology.

[7]  M. Ishihara,et al.  Glycopeptide epitope facilitates HIV-1 envelope specific humoral immune responses by eliciting T cell help , 2020, Nature Communications.

[8]  J. Greenbaum,et al.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals , 2020, Cell.

[9]  Morten Nielsen,et al.  NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data , 2020, Nucleic Acids Res..

[10]  Bjoern Peters,et al.  Benchmarking predictions of MHC class I restricted T cell epitopes in a comprehensively studied model system , 2020, PLoS Comput. Biol..

[11]  Mark M. Davis,et al.  Analyzing the M. tuberculosis immune response by T cell receptor clustering with GLIPH2 and genome-wide antigen screening , 2020, Nature Biotechnology.

[12]  Sandeep Kumar Dhanda,et al.  Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy , 2020, Journal of immunology research.

[13]  J. Ilonen,et al.  Characterization of Proinsulin T Cell Epitopes Restricted by Type 1 Diabetes–Associated HLA Class II Molecules , 2020, The Journal of Immunology.

[14]  Morten Nielsen,et al.  T Cell Epitope Predictions. , 2020, Annual review of immunology.

[15]  Sandeep Kumar Dhanda,et al.  T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species , 2020, Journal of Virology.

[16]  Andrew R. Jones,et al.  Allele frequency net database (AFND) 2020 update: gold-standard data classification, open access genotype data and new query tools , 2019, Nucleic Acids Res..

[17]  Paul Flicek,et al.  IPD-IMGT/HLA Database , 2019, Nucleic Acids Res..

[18]  A. Sette,et al.  Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions , 2020, Frontiers in Immunology.

[19]  A. Christophersen,et al.  Peptide‐MHC class I and class II tetramers: From flow to mass cytometry , 2019, HLA.

[20]  Bjoern Peters,et al.  Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease , 2019, Cell reports.

[21]  R. Rappuoli,et al.  Editorial: Reverse Vaccinology , 2019, Front. Immunol..

[22]  A. Sette,et al.  Transcriptomic immune profiles of human flavivirus‐specific T‐cell responses , 2019, Immunology.

[23]  M. Nielsen,et al.  The Immune Epitope Database and Analysis Resource Program 2003–2018: reflections and outlook , 2019, Immunogenetics.

[24]  J. Banchereau,et al.  Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination , 2019, PLoS pathogens.

[25]  D. Tscharke,et al.  Quantification of epitope abundance reveals the effect of direct and cross-presentation on influenza CTL responses , 2019, Nature Communications.

[26]  A. Sette,et al.  Non-tuberculous Mycobacteria and Heterologous Immunity to Tuberculosis. , 2019, The Journal of infectious diseases.

[27]  Morten Nielsen,et al.  IEDB-AR: immune epitope database—analysis resource in 2019 , 2019, Nucleic Acids Res..

[28]  R. Wyatt,et al.  Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease , 2019, Nature Immunology.

[29]  S. Mallal,et al.  Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles , 2019, The Journal of clinical investigation.

[30]  Julie G. Burel,et al.  Host Transcriptomics as a Tool to Identify Diagnostic and Mechanistic Immune Signatures of Tuberculosis , 2019, Front. Immunol..

[31]  V. Nizet,et al.  Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant TFH cells , 2019, Science Translational Medicine.

[32]  Bjoern Peters,et al.  Most viral peptides displayed by class I MHC on infected cells are immunogenic , 2019, Proceedings of the National Academy of Sciences.

[33]  Alessandro Sette,et al.  The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..

[34]  E. Karamooz,et al.  MR1-dependent antigen presentation. , 2018, Seminars in cell & developmental biology.

[35]  Morten Nielsen,et al.  Epitope Specific Antibodies and T Cell Receptors in the Immune Epitope Database , 2018, Front. Immunol..

[36]  C. Hsieh,et al.  Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation , 2018, Nature Reviews Immunology.

[37]  P. J. Norris,et al.  Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus–Specific CD8+ T Cells , 2018, The Journal of Immunology.

[38]  Olga T. Schubert,et al.  The in silico human surfaceome , 2018, Proceedings of the National Academy of Sciences.

[39]  C. Jancic,et al.  γδ T Lymphocytes: An Effector Cell in Autoimmunity and Infection , 2018, Front. Immunol..

[40]  J. Berzofsky,et al.  Tissue-Specific Roles of NKT Cells in Tumor Immunity , 2018, Front. Immunol..

[41]  David Gfeller,et al.  Predicting Antigen Presentation—What Could We Learn From a Million Peptides? , 2018, Front. Immunol..

[42]  S. Stevanović,et al.  Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry , 2018, Immunology.

[43]  Sandeep Kumar Dhanda,et al.  Predicting HLA CD4 Immunogenicity in Human Populations , 2018, Front. Immunol..

[44]  G. De Libero,et al.  The Conventional Nature of Non-MHC-Restricted T Cells , 2018, Front. Immunol..

[45]  Ali A. Faruqi,et al.  Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes , 2018, PloS one.

[46]  Julie G. Burel,et al.  Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis , 2018, The Journal of Immunology.

[47]  Bjoern Peters,et al.  Allergen and Epitope Targets of Mouse-Specific T Cell Responses in Allergy and Asthma , 2018, Front. Immunol..

[48]  Bjoern Peters,et al.  Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis , 2018, Science Immunology.

[49]  A. Sette,et al.  Influenza‐derived peptides cross‐react with allergens and provide asthma protection , 2017, The Journal of allergy and clinical immunology.

[50]  Julie G. Burel,et al.  Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA , 2017, Nature Communications.

[51]  D. Kaufmann,et al.  Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells , 2017, PloS one.

[52]  S. Mallal,et al.  Global Assessment of Dengue Virus-Specific CD4+ T Cell Responses in Dengue-Endemic Areas , 2017, Front. Immunol..

[53]  P. J. Norris,et al.  Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans , 2017, Journal of Virology.

[54]  Bjoern Peters,et al.  Differential Recognition of Mycobacterium tuberculosis‐Specific Epitopes as a Function of Tuberculosis Disease History , 2017, American journal of respiratory and critical care medicine.

[55]  Alessandro Sette,et al.  Identifying specificity groups in the T cell receptor repertoire , 2017, Nature.

[56]  Bjoern Peters,et al.  Experimental validation of the RATE tool for inferring HLA restrictions of T cell epitopes , 2017, BMC Immunology.

[57]  J. Greenbaum,et al.  Immunoproteomic analysis of house dust mite antigens reveals distinct classes of dominant T cell antigens according to function and serological reactivity , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[58]  Alessandro Sette,et al.  Better living through ontologies at the Immune Epitope Database , 2017, Database J. Biol. Databases Curation.

[59]  Susan A. Doyle,et al.  Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells , 2017, Science Immunology.

[60]  S. Mallal,et al.  Definition of Human Epitopes Recognized in Tetanus Toxoid and Development of an Assay Strategy to Detect Ex Vivo Tetanus CD4+ T Cell Responses , 2017, PloS one.

[61]  S. Lemieux,et al.  MHC class I-associated peptides derive from selective regions of the human genome. , 2016, The Journal of clinical investigation.

[62]  S. Mallal,et al.  Sequence conservation predicts T cell reactivity against ragweed allergens , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[63]  Alessandro Sette,et al.  A Cytokine-Independent Approach To Identify Antigen-Specific Human Germinal Center T Follicular Helper Cells and Rare Antigen-Specific CD4+ T Cells in Blood , 2016, The Journal of Immunology.

[64]  J. Greenbaum,et al.  T-cell epitope conservation across allergen species is a major determinant of immunogenicity. , 2016, The Journal of allergy and clinical immunology.

[65]  Bjoern Peters,et al.  A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans , 2016, PLoS pathogens.

[66]  Bali Pulendran,et al.  Cytokine-Independent Detection of Antigen-Specific Germinal Center T Follicular Helper Cells in Immunized Nonhuman Primates Using a Live Cell Activation-Induced Marker Technique , 2016, The Journal of Immunology.

[67]  J. Greenbaum,et al.  Lack of allergy to timothy grass pollen is not a passive phenomenon but associated with the allergen‐specific modulation of immune reactivity , 2016, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[68]  J. Greenbaum,et al.  T‐cell recognition is shaped by epitope sequence conservation in the host proteome and microbiome , 2016, Immunology.

[69]  E. Tartour,et al.  Immunoprevalence and magnitude of HLA-DP4 versus HLA-DR-restricted spontaneous CD4+ Th1 responses against telomerase in cancer patients , 2016, Oncoimmunology.

[70]  Bjoern Peters,et al.  Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets. , 2015, The Journal of infectious diseases.

[71]  Bjoern Peters,et al.  Automatic Generation of Validated Specific Epitope Sets , 2015, Journal of immunology research.

[72]  Bjoern Peters,et al.  Definition of a pool of epitopes that recapitulates the T cell reactivity against major house dust mite allergens , 2015, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[73]  Mark M. Davis,et al.  A Population Response Analysis Approach To Assign Class II HLA-Epitope Restrictions , 2015, The Journal of Immunology.

[74]  L. Waldron,et al.  Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array , 2015, Clinical Cancer Research.

[75]  Ruedi Aebersold,et al.  A Mass Spectrometric-Derived Cell Surface Protein Atlas , 2015, PloS one.

[76]  Andrew R Jones,et al.  A bioinformatics tool for epitope-based vaccine design that accounts for human ethnic diversity: application to emerging infectious diseases. , 2015, Vaccine.

[77]  J. Greenbaum,et al.  Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopes , 2014, Proceedings of the National Academy of Sciences.

[78]  Bjoern Peters,et al.  The Human CD8+ T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes , 2014, Journal of Virology.

[79]  John Sidney,et al.  Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes , 2014, BCB.

[80]  Bjoern Peters,et al.  Transcriptional Profile of Tuberculosis Antigen–Specific T Cells Reveals Novel Multifunctional Features , 2014, The Journal of Immunology.

[81]  Bjoern Peters,et al.  Immunodominance Changes as a Function of the Infecting Dengue Virus Serotype and Primary versus Secondary Infection , 2014, Journal of Virology.

[82]  J. Sidney,et al.  Impact of Distinct Poxvirus Infections on the Specificities and Functionalities of CD4+ T Cell Responses , 2014, Journal of Virology.

[83]  L. Klein,et al.  Positive and negative selection of the T cell repertoire: what thymocytes see (and don't see) , 2014, Nature Reviews Immunology.

[84]  M. Carrington,et al.  Broadly Reactive Human CD8 T Cells that Recognize an Epitope Conserved between VZV, HSV and EBV , 2014, PLoS pathogens.

[85]  Alessandro Sette,et al.  Definition of CD4 Immunosignatures Associated with MTB , 2014, Front. Immunol..

[86]  Ravi V. Kolla,et al.  Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells , 2013, Proceedings of the National Academy of Sciences.

[87]  Peter Cresswell,et al.  Pathways of antigen processing. , 2013, Annual review of immunology.

[88]  Ravi V. Kolla,et al.  Previously undescribed grass pollen antigens are the major inducers of T helper 2 cytokine-producing T cells in allergic individuals , 2013, Proceedings of the National Academy of Sciences.

[89]  Bjoern Peters,et al.  A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population , 2013, Immunogenetics.

[90]  Clemencia Pinilla,et al.  Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.

[91]  Bjoern Peters,et al.  Memory T Cells in Latent Mycobacterium tuberculosis Infection Are Directed against Three Antigenic Islands and Largely Contained in a CXCR3+CCR6+ Th1 Subset , 2013, PLoS pathogens.

[92]  Bjoern Peters,et al.  The immune epitope database: a historical retrospective of the first decade , 2012, Immunology.

[93]  Ravi V. Kolla,et al.  T Cell Responses to Known Allergen Proteins Are Differently Polarized and Account for a Variable Fraction of Total Response to Allergen Extracts , 2012, The Journal of Immunology.

[94]  Ravi V. Kolla,et al.  Analysis of T Cell Responses to the Major Allergens from German Cockroach: Epitope Specificity and Relationship to IgE Production , 2012, The Journal of Immunology.

[95]  Morten Nielsen,et al.  Peptide‐MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity , 2012, European journal of immunology.

[96]  G. Nepom MHC Class II Tetramers , 2012, The Journal of Immunology.

[97]  D. Kasper,et al.  A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design , 2011, Nature Medicine.

[98]  Søren Buus,et al.  Real-time, high-throughput measurements of peptide-MHC-I dissociation using a scintillation proximity assay. , 2011, Journal of immunological methods.

[99]  D. Kasper,et al.  A novel mechanism for glycoconjugate vaccine activation of the adaptive immune system , 2012 .

[100]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[101]  Morten Nielsen,et al.  MHC Class II epitope predictive algorithms , 2010, Immunology.

[102]  Bjoern Peters,et al.  Molecular Determinants of T Cell Epitope Recognition to the Common Timothy Grass Allergen , 2010, The Journal of Immunology.

[103]  F. Ennis,et al.  Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens. , 2010, Future microbiology.

[104]  A. Sharpe,et al.  Taming tissue-specific T cells: CTLA-4 reins in self-reactive T cells , 2010, Nature Immunology.

[105]  Bjoern Peters,et al.  Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population , 2009, Proceedings of the National Academy of Sciences.

[106]  Bjoern Peters,et al.  Diverse recognition of conserved orthopoxvirus CD8+ T cell epitopes in vaccinated rhesus macaques. , 2009, Vaccine.

[107]  F. Sallusto,et al.  Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells , 2009, The Journal of experimental medicine.

[108]  Rong-Fu Wang Molecular Cloning and Characterization of MHC Class I– and II–Restricted Tumor Antigens Recognized by T Cells , 2009, Current protocols in immunology.

[109]  A. Sette,et al.  The curation guidelines of the immune epitope database and analysis resource , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[110]  P. Dellabona,et al.  Use of MHC class II tetramers to investigate CD4+ T cell responses: Problems and solutions , 2008, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[111]  Magdalini Moutaftsi,et al.  Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve1 , 2008, The Journal of Immunology.

[112]  J. Greenbaum,et al.  Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes , 2008, Proceedings of the National Academy of Sciences.

[113]  Bjoern Peters,et al.  HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.

[114]  Bjoern Peters,et al.  A Quantitative Analysis of the Variables Affecting the Repertoire of T Cell Specificities Recognized after Vaccinia Virus Infection1 , 2007, The Journal of Immunology.

[115]  Bjoern Peters,et al.  The CD8+ T-Cell Response to Lymphocytic Choriomeningitis Virus Involves the L Antigen: Uncovering New Tricks for an Old Virus , 2007, Journal of Virology.

[116]  J. Yewdell,et al.  Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. , 2006, Immunity.

[117]  Robyn L Stanfield,et al.  How TCRs bind MHCs, peptides, and coreceptors. , 2006, Annual review of immunology.

[118]  John Sidney,et al.  Predicting population coverage of T-cell epitope-based diagnostics and vaccines , 2006, BMC Bioinformatics.

[119]  T. Schumacher,et al.  MHC multimer technology: current status and future prospects. , 2005, Current opinion in immunology.

[120]  John Sidney,et al.  Classification of A1- and A24-supertype molecules by analysis of their MHC-peptide binding repertoires , 2005, Immunogenetics.

[121]  Ellis L. Reinherz,et al.  PEPVAC: a web server for multi-epitope vaccine development based on the prediction of supertypic MHC ligands , 2005, Nucleic Acids Res..

[122]  O. Lund,et al.  The design and implementation of the immune epitope database and analysis resource , 2005, Immunogenetics.

[123]  O. Lund,et al.  Definition of supertypes for HLA molecules using clustering of specificity matrices , 2004, Immunogenetics.

[124]  A. McMichael HLA restriction of human cytotoxic T cells , 1980, Springer Seminars in Immunopathology.

[125]  H. Grey,et al.  Major histocompatibility complex class II association and induction of T cell responses by carbohydrates and glycopeptides , 1993, Springer Seminars in Immunopathology.

[126]  John Sidney,et al.  Simultaneous Prediction of Binding Capacity for Multiple Molecules of the HLA B44 Supertype 1 , 2003, The Journal of Immunology.

[127]  D. Koelle Expression cloning for the discovery of viral antigens and epitopes recognized by T cells. , 2003, Methods.

[128]  J. Altman,et al.  MHC‐Peptide Tetramers to Visualize Antigen‐Specific T Cells , 2003, Current protocols in immunology.

[129]  H. Reijonen,et al.  HLA class II tetramers: tools for direct analysis of antigen-specific CD4+ T cells. , 2002, Arthritis and rheumatism.

[130]  A Sette,et al.  Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules. , 2001, Human immunology.

[131]  John Sidney,et al.  Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes , 2001, Journal of Virology.

[132]  P. Openshaw,et al.  Flow cytometric measurement of intracellular cytokines. , 2000, Journal of immunological methods.

[133]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[134]  L. Karlsson,et al.  Nonclassical MHC class II molecules. , 2000, Annual review of immunology.

[135]  J. Sidney,et al.  Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.

[136]  A. McMichael,et al.  Functions of nonclassical MHC and non-MHC-encoded class I molecules. , 1999, Current opinion in immunology.

[137]  J. Yewdell,et al.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. , 1999, Annual review of immunology.

[138]  J. Sidney,et al.  HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.

[139]  M F del Guercio,et al.  Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.

[140]  P. Cresswell,et al.  Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.

[141]  D. Vignali,et al.  T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. , 1997, Immunity.

[142]  M F del Guercio,et al.  Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. , 1996, Journal of immunology.

[143]  A Sette,et al.  Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.

[144]  M F del Guercio,et al.  Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. , 1996, Human immunology.

[145]  M F del Guercio,et al.  Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.

[146]  D. Madden The three-dimensional structure of peptide-MHC complexes. , 1995, Annual review of immunology.

[147]  A. Vitiello,et al.  The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.

[148]  C Oseroff,et al.  Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. , 1994, Immunity.

[149]  A. Vitiello,et al.  Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein , 1993, Journal of virology.

[150]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[151]  Peter Walden,et al.  Exact prediction of a natural T cell epitope , 1991, European journal of immunology.

[152]  A Sette,et al.  Truncation analysis of several DR binding epitopes. , 1991, Journal of immunology.

[153]  R W Chesnut,et al.  Characterization of the specificity of peptide binding to four DR haplotypes. , 1990, Journal of immunology.

[154]  J. Rothbard,et al.  Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. , 1990, International immunology.

[155]  H. Grey,et al.  The use of peptide analogs with improved stability and MHC binding capacity to inhibit antigen presentation in vitro and in vivo. , 1990, Journal of immunology.

[156]  P. Cresswell,et al.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR. , 1990, Journal of immunology.

[157]  Antonio Lanzavecchia,et al.  Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells , 1989, European journal of immunology.

[158]  M. Bekoff,et al.  Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[159]  A. Trzeciak,et al.  A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules , 1988, Nature.

[160]  A Sette,et al.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.

[161]  Alessandro Sette,et al.  Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells , 1987, Nature.

[162]  O Ouchterlony,et al.  A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[163]  J. Woody,et al.  Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones. , 1982, Journal of immunology.

[164]  C. Barnstable,et al.  Monoclonal Antibodies for Analysis of the HLA System , 1979, Immunological reviews.